PP
UTHR icon

PDT Partners’s United Therapeutics UTHR Stock Holding History

PDT Partners’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-700
Closed -$216K – 849
2025
Q1 		$216K Sell
700
-2
-0.3% -$685 0.02% 667
2024
Q4 		$248K Sell
702
-278
-28% -$102K 0.02% 618
2024
Q3 		$351K Sell
980
-5,560
-85% -$1.88M 0.03% 576
2024
Q2 		$2.08M Buy
6,540
+700
+12% +$185K 0.2% 196
2024
Q1 		$1.34M Sell
5,840
-3,607
-38% -$814K 0.13% 270
2023
Q4 		$2.08M Sell
9,447
-8,175
-46% -$1.88M 0.23% 140
2023
Q3 		$3.98M Buy
17,622
+5
+0% +$1.15K 0.5% 29
2023
Q2 		$3.89M Buy
17,617
+5,548
+46% +$1.23M 0.53% 38
2023
Q1 		$2.7M Buy
12,069
+9,369
+347% +$2.31M 0.37% 87
2022
Q4 		$751K Buy
+2,700
New +$682K 0.12% 307
2022
Q2 		– Sell
-6,065
Closed -$1.09M – 1168
2022
Q1 		$1.09M Buy
+6,065
New +$1.16M 0.09% 342
2020
Q1 		– Sell
-3,008
Closed -$265K – 866
2019
Q4 		$265K Buy
+3,008
New +$265K 0.02% 572
2016
Q1 		– Sell
-4,700
Closed -$736K – 602
2015
Q4 		$736K Sell
4,700
-50,998
-92% -$7.42M 0.1% 239
2015
Q3 		$7.31M Buy
55,698
+5,400
+11% +$866K 0.16% 164
2015
Q2 		$8.75M Sell
50,298
-7,806
-13% -$1.4M 0.23% 96
2015
Q1 		$10M Buy
58,104
+50,768
+692% +$7.74M 0.25% 93
2014
Q4 		$950K Buy
+7,336
New +$945K 0.09% 318
2014
Q3 		– Sell
-85,213
Closed -$7.54M – 1600
2014
Q2 		$7.54M Sell
85,213
-12,297
-13% -$1.18M 0.2% 116
2014
Q1 		$9.17M Buy
+97,510
New +$9.97M 0.22% 118
2013
Q4 		– Sell
-17,865
Closed -$1.41M – 1163
2013
Q3 		$1.41M Buy
+17,865
New +$1.31M 0.04% 637

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

PDT Partners's UTHR Position: Q2 2025 in Review

PDT Partners sold out of United Therapeutics (UTHR) in Q2 2025, closing a stake of 700 shares — an estimated $216K sold.

PDT Partners first reported a position in UTHR in Q3 2013 and held it in 20 quarters. The position peaked at $10M in Q1 2015. 671 funds tracked by Wall St. Rank hold UTHR as of Q2 2025.

  • PDT Partners reported no remaining United Therapeutics position as of Q2 2025 after selling out during the quarter.
  • PDT Partners sold 700 United Therapeutics shares in Q2 2025, an estimated $216K.
  • PDT Partners first reported a position in United Therapeutics in Q3 2013 and held it in 20 quarters.
  • PDT Partners's United Therapeutics position peaked at $10M in Q1 2015.
  • 671 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2025.

Based on PDT Partners's 13F filing for Q2 2025, filed 14 Aug 2025.